Related Experiment Video

Updated: Jun 20, 2026

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
11:38

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on: September 14, 2021

Noncanonical transforming growth factor beta signaling in scleroderma fibrosis

Maria Trojanowska1

  • 1Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, South Carolina 29425, USA. trojanme@musc.edu

Current Opinion in Rheumatology
|August 29, 2009
PubMed
Abstract

Insights

Noncanonical transforming growth factor beta (TGF-beta) pathways drive scleroderma (SSc) fibrosis by activating Smad1 and reducing antifibrotic factors. Targeting these pathways offers new therapeutic strategies for SSc.

Area of Science:

  • Fibrosis research
  • Cell signaling
  • Scleroderma pathogenesis

Background:

  • Persistent transforming growth factor beta (TGF-beta) signaling is a key driver of fibrosis in scleroderma (SSc).
  • Canonical TGF-beta signaling involves Smad2/3 activation.
  • Noncanonical pathways represent alternative signaling routes activated by TGF-beta.

Purpose of the Study:

  • To review recent advancements in understanding noncanonical TGF-beta signaling pathways.
  • To elucidate the role of these pathways in SSc fibrosis.

Main Methods:

  • Review of existing literature on TGF-beta signaling in SSc.
  • Analysis of molecular mechanisms in SSc fibroblasts.

Main Results:

  • Noncanonical TGF-beta signaling activates pathways independently of Smad2/3.
  • A subset of SSc fibroblasts shows constitutive Smad1 activation via TGF-beta and CCN2 receptors, creating an autocrine loop.
  • SSc fibroblasts exhibit reduced expression of TGF-beta antagonists like PTEN, Friend leukemia integration-1, and perixosome proliferator-activated receptor-gamma.

Conclusions:

  • Noncanonical TGF-beta signaling pathways present novel molecular targets for antifibrotic therapies in SSc.
  • Understanding these pathways can facilitate personalized treatment strategies based on specific profibrotic pathway activation in individual SSc patients.

More Related Videos

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...